Cargando…
Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review
RATIONALE: Small cell lung cancer (SCLC) is a lethal malignancy. Once relapsed, the disease is irreversible and most of the patients will die of cancer aggravation in 1 to 2 months. In the past several decades, little progress has been made in the systemic treatment of SCLC. Apatinib, as a novel sma...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815779/ https://www.ncbi.nlm.nih.gov/pubmed/29390367 http://dx.doi.org/10.1097/MD.0000000000009259 |